The FDA has approved a new medication that will boost libido in women with low sexual desire, so that they too can have an enjoyable sex life.
We’ve long seen advertisements for drugs like Cialis or Viagra, which help to improve sexual performance in men with erectile dysfunction. But on Friday, the U.S. Food and Drug Administration approved a new medication that will boost libido in women with low sexual desire, so that they too can have an enjoyable sex life.
“Clinicians don’t have a process for diagnosing and addressing it,” Dr. Sharon Parish, professor of medicine in clinical psychiatry at Weill Cornell Medical College, told ABC News. “It’s under-recognized.” Lindsay, who participated in the trial for Vyleesi, said that she’s now on a “couple of medications that have helped me manage so that I can feel comfortable being intimate with my husband, even if it’s not something where I have spontaneous desire to do so.”
Although an injection drug might turn some women off of using it, Dr. Carl Spana, president and CEO of Palatin Pharmaceuticals, which makes Vyleesi, said it shouldn’t be a concern because the needle is tiny — it comes as an injectable pen.Sue Goldstein, a clinical sexual educator and author of the book “When Sex Isn’t Good,” told ABC News about her HSDD and how she had been treated with Addyi successfully. She was also involved in coordinating clinical trials for the drug.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
The New Sex Drug Is Called VyleesiThe FDA just approved a new drug aimed at revving up women’s libidos and treating 'low sexual drive,' and it's called 'Vyleesi'
Consulte Mais informação »
64% Of New Hires Will Leave Their Jobs Because Of This Experience, A New Survey ShowsMore than half of new hires can trace their decision to leave back to one specific experience with the company.
Consulte Mais informação »
64% Of New Hires Will Leave Their Jobs Because Of This Experience, A New Survey ShowsMore than half of new hires can trace their decision to leave back to one specific experience with the company.
Consulte Mais informação »